★★★★★ 5
Day 1 and A Week ish Later
Size: 30 Count (Pack of 1)
I was taking Olly Stress Relief gummies for a while to control anxiety, hyperactivity and racing thoughts, and they worked great. Recently I noticed that they were becoming a lot less effective and started searching for alternatives. This was my first choice and I've only used it this morning. Took one pill. So far I have noticed a lighter mood, lack of racing thoughts, and an overall feeling of being slowed down. I can focus on conversations better, and it slightly enhanced my ability to taste, flavors seem more vibrant.. I am a bit more "lazy feeling" as others mentioned, and I did get the lavender burps. They're not horribly obnoxious for me, just a bit different. Burps lasted maybe half an hour. So far I like it.
Edit: it's been over a week now. The first few days I dealt with random headaches on and off, but did get benefits as stated above. After my body adjusted I stopped having the headaches and the "lazy" feeling. The lavender burps are still a thing and so is short term lavender breath right after taking a pill. You can describe it like a light lingering, kinda like toothpaste has a minty aftertaste, but lavender instead. For the most part I would still say it helps. It does not hit as hard as the first few days, but it is helping somewhat.
Benefits for me: Less overstimulation in public, better ability to relax after work, anxiety is more "inconvenience", easier to focus, deeper sleep, less irritability.
Cons for me: Short term lavender breath, vivid and unusual dreams, 2-3 day initial adjustment period for unpleasant side effects.
What I'm doing: Taking one pill around 7-7:30pm daily with lots of water. Taking late to sleep off any potential unpleasant initial effects, and get better sleep.
WAS THIS REVIEW HELPFUL?YesReportShare
Reviewed in the United States on August 31, 2024
![glp 1 roche Ad hoc announcement pursuant to Art. 53 LR] Roche announces positive Phase I results of its oral GLP-1 receptor agonist CT-996 for the treatment of people with obesity](https://a.storyblok.com/f/176343/1920x1281/9879d12165/roche_270354.jpeg "glp 1 roche Ad hoc announcement pursuant to Art. 53 LR] Roche announces positive Phase I results of its oral GLP-1 receptor agonist CT-996 for the treatment of people with obesity")
![glp 1 roche Ad hoc announcement pursuant to Art. 53 LR] Roche announces positive Phase I results of its oral GLP-1 receptor agonist CT-996 for the treatment of people with obesity](https://www.gnc.com/dw/image/v2/BBLB_PRD/on/demandware.static/-/Sites-master-catalog-gnc/default/dw6c9214a2/hi-res/187612_1.jpg?sw=305&sh=305&sm=fit "glp 1 roche Ad hoc announcement pursuant to Art. 53 LR] Roche announces positive Phase I results of its oral GLP-1 receptor agonist CT-996 for the treatment of people with obesity")
![glp 1 roche Ad hoc announcement pursuant to Art. 53 LR] Roche announces positive Phase I results of its oral GLP-1 receptor agonist CT-996 for the treatment of people with obesity](https://eatingdisordersolutions.com/wp-content/uploads/2025/09/GLP-1-and-eating-disorders.png "glp 1 roche Ad hoc announcement pursuant to Art. 53 LR] Roche announces positive Phase I results of its oral GLP-1 receptor agonist CT-996 for the treatment of people with obesity")
![glp 1 roche Ad hoc announcement pursuant to Art. 53 LR] Roche announces positive Phase I results of its oral GLP-1 receptor agonist CT-996 for the treatment of people with obesity](https://www.professionalsupplementcenter.com/cdn/shop/files/glp-1-probiotic-CDE_main_5.jpg?v=1768933426&width=800 "glp 1 roche Ad hoc announcement pursuant to Art. 53 LR] Roche announces positive Phase I results of its oral GLP-1 receptor agonist CT-996 for the treatment of people with obesity")
